Quarterly report pursuant to Section 13 or 15(d)

Balance Sheet Components - Breakdown of the Company Revenue (Details)

v3.22.1
Balance Sheet Components - Breakdown of the Company Revenue (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Concentration Risk [Line Items]    
Revenues $ 80,385 $ 86,932
U.S. revenue    
Concentration Risk [Line Items]    
Revenues 52,444 71,212
Non-U.S. revenue    
Concentration Risk [Line Items]    
Revenues $ 27,941 $ 15,720